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Table 1
Prevalence of OA divided by subgroups of OA
PFOA TFOA COA No radiographic OA Total
Baseline 83 0 0 629 712
2 year 51 53 68 547 719
5 year 76 73 86 468 703
Abstracts / Osteoarthritis and Cartilage 23 (2015) A26eA81A42but not in Tlr2 null cells (0.9-fold, p¼0.5), suggesting that these effects
are mediated through TLR2. DRG cells also respond to a synthetic TLR2
ligand (Pam3CSK4, 10 mM, 7.7-fold, p<0.001), providing additional
evidence that TLR2 signaling can lead to MCP-1 upregulation.
Conclusions: These studies suggest that, through TLR2, nociceptors
have the ability to respond to a speciﬁc 32-mer cleavage product of
aggrecan. This pathway may play a role in the development of osteo-
arthritis-associated pain.
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GREMLIN1 INDUCED BY EXCESSIVE MECHANICAL STRESS LOADING
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Purpose: Excessive mechanical stress loading on articular cartilage is
one of the major factors of osteoarthritis (OA); however, the molecular
mechanisms of cartilage degradation by such loading remain unclear.
The present study therefore analyzed gene expression proﬁles of
articular chondrocytes under mechanical stress loading and inves-
tigated functions of the candidate gene.
Methods: We applied an uni-axial cyclic cell stretch (0.5 Hz, 10%
stretch, for 30 min) to primary articular chondrocytes obtained from
mouse knee joint by STB-140 (STREX), and performed cDNA micro-
array analysis using the samples before and after the loading. We also
applied excessive hydrostatic pressure (0.1 Hz, 20 MPa, for 30 min) to
3-week-old mouse femoral heads by a custom-made device, and
compared the results in both systems. The gene expressions were
conﬁrmed by real-time RT-PCR and immunohistochemistry. The
catabolic ability was assessed by measuring the concentration of
aggrecan released from cultured 3-week-old mouse femoral heads
using the dimethylmethylene blue dye-binding assay. We used mouse
primary articular chondrocytes and mouse chondrogenic cell line
ATDC5 for in vitro functional analyses. We further examined in vivo
effects of a candidate gene using a surgical OA model of mouse knee
joint.
Results: Microarray analyses revealed that 2,076 genes were increased
more than twice by the cell stretch. Among them, we focused on
Gremlin1 (Grem1), which is one of the most highly expressed genes.
Grem1 is known to be a secretory protein that regulates limb devel-
opment, although its function in articular cartilage is unknown.
Immunocytochemistry conﬁrmed that Grem1 protein was increased in
cytoplasm of articular chondrocytes by the cell stretch. Grem1 mRNA
expression was also increased in mouse femoral heads under exces-
sive cyclic hydrostatic pressure. Immunoﬂuorescence further revealed
that Grem1 protein was increased on the cell surface of articular
chondrocytes during OA development of the mouse model. In primary
culture of mouse articular chondrocytes, recombinant human (rh)
GREM1 treatment or adenoviral overexpression of Grem1 induced the
expressions of catabolic factors including Mmp13 and Adamts5, and
suppressed those of anabolic factors including Col2a1, Aggrecan and
Sox9. Similar results were observed in ATDC5 by lentiviral trans-
duction of Grem1. Microarray analyses showed that other various
catabolic and inﬂammatory factors, such as Mmp3, Mmp8, Il1b (IL-1b),
and Il6 (IL-6), were signiﬁcantly upregulated by the rhGREM1 treat-
ment in mouse articular chondrocytes. In the organ culture of mouse
femoral heads, rhGREM1 treatment increased aggrecan release into
the medium in a dose-dependent manner. In the mouse OA model,
intra-articular injection of rhGREM1 exacerbated cartilage degrada-
tion. In contrast, intra-articular injection of Grem1 neutralizing anti-
body inhibited OA development.
We further found that Grem1 enhanced the NF-kB signaling activation
by luciferase assay. Notably, in the organ culture of femoral heads, the
increased aggrecan release by the rhGREM1 treatment was completely
cancelled by gene deletion of p65/Rela, or an IKK inhibitor (BMS-
345541) treatment, indicating that the catabolic effects of Grem1 were
mediated by the NF-kB signaling pathway.
Conclusions: Grem1 is induced by excessive mechanical stress loading,
and exerts catabolic effects on articular cartilage through the NF-kB
signaling pathway. Grem1 may be a novel therapeutic target of OA.31
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Purpose: Most research in osteoarthritis (OA) has focused on the
tibiofemoral (TF)-joint, although it is proposed that signs of patellofe-
moral (PFOA), opposed to TFOA, are associated with pain symptoms and
disability. Additionally, it is suggests that OA in the knee starts in the PF
joint and progresses to the TF joint. Therefore, this study addresses the
following aims: 1. Determine the prevalence and incidence of PFOA
compared to TFOA in patients with a recent onset of knee pain 2.
Describe the natural course of both PFOA and TFOA after 2 and 5 years
follow-up and 3. Identify if patients with PFOA have a different phe-
notype compared to patients with TFOA, or patients with combined
PFOA and TFOA.
Methods: For this study data of the Cohort Hip and Cohort Knee
study (CHECK) were used (n¼ 1002). Patients with early OA symp-
toms of the knee were selected. All patients completed a ques-
tionnaire and underwent physical examination at baseline and after 2
and 5 years follow-up. At each time-point, three radiographs of the
knee were obtained (Anterior-Posterior, skyline and lateral). Follow-
ing these radiographs, all patients were classiﬁed into four different
groups: isolated TFOA, isolated PFOA, combined (TF and PF) OA (COA)
or no radiographic OA. Only the knee with most severe symptoms
per patient was analyzed. Multivariate backward stepwise binary
logistic regression (p<.05) was used to identify if patient character-
istics and characteristics from physical examination were associated
with a speciﬁc group of OA patients. The following variables were
included in the regression analyses: gender, age, body mass index
(BMI), baseline pain, bony tenderness during palpation, crepitus in
the knee duration ﬂexion, degrees of knee ﬂexion, patellar grinding
test.
Results: The total cohort comprised 845 patients (80% females) with a
mean age of 55.3 (5.18) years. The prevalence and incidence of the
different types of OA are presented in Table 1. At baseline the majority
of patients had no radiographic signs of OA. The natural course of the
different patient subgroups is presented in Figure 1. Twenty-seven out
of the 83 patients who had PFOA at baseline remained to have PFOA
at 5 years follow-up; 56 developed COA after two to ﬁve yours follow-
up.
Patients with PFOA at baseline were more likely to have a higher BMI
(OR (95%CI) 1.09 (1.03;1.16), higher age (1.07 (1.01;1.13), positive
patellar grinding test (1.92 (1.12;3.29) and palpable bony tenderness
of the knee (2.90 (1.09;7.76) compared to patients without radio-
graphic OA at baseline. After two years, patients with PFOA did not
differ from patients with TFOA, however patients with PFOA, had
lower BMI scores at baseline compared to patients with COA (OR (95%
CI) 0.90 (0.82;0.99).However no differences were seen after ﬁve
year follow-up. Patients with signs of PFOA at baseline who did
not develop COA after 5 years had signiﬁcantly higher active knee
ﬂexion range of motion (ROM), compared to patients who had PFOA
at baseline and developed COA at follow-up (OR (95%CI) 1.10
(1.01;1.20).
Conclusions: After 5 years follow-up 33% of the primary care patients
with knee pain had developed OA (PFOA, TFOA or COA). About one third
of the patients with PFOA still have PFOA after 5 years and these
patients distinguish in a high active knee ﬂexion ROM. Patients with
PFOA at baseline signiﬁcantly differ from patients without any signs of
radiographic OA at baseline. However phenotypes of patients with
PFOA do not seem to differ from patients with TFOA or COA.
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Purpose: Our aim is to better understand the pathomolecular mecha-
nisms involved in OA. By studying molecular components across dif-
ferent OA joints we could perhaps understand the similarities,
disparities and identify key molecular mechanisms driving OA. High-
throughput comparative proteomics approaches offer a powerful
insight into the common and different molecules and their regulatory
mechanisms present in these two different OA joints.
Methods: Human cartilage samples obtained from carpometacarpal of
the thumb (CMC-I) and knee OA were immunostained for TLRs (1-9)
and analyzed using histomorphometry and principal component
analysis (PCA). mRNA was extracted and expression levels were ana-
lyzed by RT-PCR. Synovial ﬂuid (SF) was obtained from (CMC-I) OA
(n¼10) and knee OA (n¼10) patients. SF samples were albumin
depleted and analyzed in liquid mass spectrometry (LC/MS). Selected
molecules were validated by enzyme-linked immunosorbent assay
(ELISA).
Results: Contrary to the observed homogenous TLR expression in knee
OA (p<0.05), TLRs did not display grade-dependent overall proﬁle
changes in CMC-I OA, however PCA revealed that TLR expression
proﬁles clustered accordingly to their known cellular compartmen-
talization. We observed an atypical TLR4 expression at the mRNA
(increased) and protein level (decreased) in CMC-I OA cartilage in
comparison to equivalent-graded knee OA cartilage (data not shown).
This led us to believe that perhaps relevant molecules and regulatory
mechanism are differentially regulated between the two joints. SF
analysis with speciﬁc ELISAs for soluble biglycan (BGN) and soluble
toll-like receptor (TLR4) disclosed signiﬁcant differences on the pres-
ence of these catabolic and negative regulative molecules, respectively
(Figure 1).Figure 1. Box plot representation of soluble Biglycan and TLR4 Concen-
tration levels in synovial ﬂuid obtained from arthritic patients.
Our high-throughput approach by Comparative SF proteomic analysis
revealed that 120 commonly present proteins were differentially regu-
lated in knee and CMC-I joints, with 65 proteins being over expressed by
1.3 fold difference. In additionwe identiﬁed 41 newproteinswhich have
never been reported to be present in OA synovial ﬂuid. Bioinformatic
analysis of the differential regulated proteins reveal their signiﬁcant
participation in different molecular functions (Figure 2).Figure 2. Gene ontology analysis of differentially expressed proteins in
synovialﬂuid fromCMC-I and knee OA joints. (PANTHER analysis Pathway).
Conclusions: Our results from classical immunohistochemistry and
immunoassay techniques (IHC and ELISA) combined with forefront
Proteomics techniques (LC/MS) conﬁrm the differential expression of
several keymolecular players in CMC-I and knee OA. Taken together our
study trongly suggest that pathomolecular mechanisms of OA may
differ depending on the affected joint. The reported molecules are
putative biomarkers of OA and potential therapeutic targets for OA.
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Purpose: Progranulin (PGRN) was previously reported as an osteo-
arthritis (OA)-associated growth factor. This study aims to investigate
the role of PGRN in the pathogenesis of OA in vivo.
Methods: Progression of OA was analyzed by surgically induced OA
models in wild type, PGRN-deﬁcient, TNFR1-deﬁcient and TNFR2-
deﬁcient mice. Cartilage degradation and OA severity were evaluated
using Safranin O and HE staining, immunohistochemistry and ELISA.
Additionally, mRNA expression of degenerative factors and catabolic
markers known to be involved in cartilage degeneration in OA were
analyzed.
Results: 1. Deﬁciency of PGRN leads to exaggerated osteoarthritis pro-
gression in destabilization of the medial meniscus mice model. To
determine the role of PGRN in the course of OA progression, we used a
surgically induced OA mice model, destabilization of the medial
meniscus(DMM) mice model in both wild type and PGRN-deﬁcient
mice. Safranin O staining revealed that more severe structure loss was
presented in PGRN-deﬁcient mice than in WT mice (Fig. 1A). Osteo-
arthritis Research Society International (OARSI) scoring of OA was
performed, and demonstrated that PGRN-deﬁcient mice had a sig-
niﬁcantly higher arthritic score than theWTgroup at all the time points
(Fig.1B). COMP degradation is widely used as a biomarker for OA pro-
gression COMP fragment-speciﬁc ELISA revealed that deﬁciency of
PGRN exaggerated degradation of COMP after DMM operation
(Fig. 1C).Additionally, synovium inﬂammation and osteophyte for-
mation of WT and PGRN/mice knee joint at 4 weeks after induction
were assayed through histology (Fig.1D), PGRN-deﬁcient mice pre-
sented markedly more severe synovium inﬂammation as well as
osteophyte formation compared with WT littermates. The immuno-
histochemistry staining demonstrated stronger positive signals for Col
X, MMP13 and COMP fragments in PGRN-deﬁcient group thanwild type
group at 8 weeks after DMM operation (Fig. 1E).
2. Recombinant PGRN protects against OA in anterior cruciate ligament
transection model through the TNFR2 pathway in vivo.
To investigate whether recombinant PGRN has a protective effect
against induction and development of OA, anterior cruciate ligament
transection(ACLT) model was established in wild type, TNFR1-deﬁcient
and TNFR2-deﬁcient mice (n¼7 for each group), followed by intra-
articular injection of phosphate buffered saline (PBS) or PGRN (6 mg)
once a week for 4 weeks. As shown in Fig.2A, surgically induced OA
caused destruction of articular cartilage in all three genotypes of mice
